Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, published by WILEY, is a premier journal dedicated to advancing knowledge in the fields of developmental neuroscience, clinical neurology, and pediatrics. With an impressive impact factor, this journal is recognized for its contributions, achieving Q1 ranking in both Pediatrics, Perinatology and Child Health, and Neurology (Clinical) sectors, as well as Q2 in Developmental Neuroscience. Since its inception in 1958, the journal has been at the forefront of disseminating vital research that informs clinical practice and enhances child health outcomes. Researchers and practitioners benefit from its high-quality, peer-reviewed articles that address critical issues in child neurology, underpinned by a robust Scopus ranking and a formidable percentile standing in relevant categories. While currently not an open-access journal, it remains a key resource for those dedicated to the study of child development, particularly at its intersection with neurological health. With a commitment to excellence, DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY is an essential read for anyone engaged in the care and research of pediatric populations.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Autism & Developmental Language Impairments is a pioneering peer-reviewed journal published by SAGE Publications Inc that focuses on advancing the understanding of autism spectrum disorders and language impairments across the developmental spectrum. Since its inception in 2016, this open access journal has provided a platform for researchers, practitioners, and educators to disseminate innovative research findings, clinical practices, and theoretical insights, reaching a global audience. The journal is notably indexed in prestigious databases and has established its credibility with a remarkable Rank of Q2 in both Clinical Psychology and Developmental and Educational Psychology as of 2023, solidifying its importance in these vital fields. Based in the United Kingdom, it addresses crucial issues in mental health, reflecting a commitment to fostering advancements that seek to enhance the lives of individuals affected by developmental language impairments. As it converges into its next phase from 2016 to 2024, Autism & Developmental Language Impairments continues to play an essential role in bridging gaps between academia and practice, making it an invaluable resource for researchers, clinicians, and students dedicated to this critical area of study.

Advances in Autism is a prominent academic journal published by Emerald Group Publishing Ltd, dedicated to the comprehensive exploration of autism spectrum disorders through the lenses of Cognitive Neuroscience, Developmental Psychology, and Psychiatry and Mental Health. Since its inception in 2015, the journal has made significant strides in disseminating high-quality research and fostering interdisciplinary collaboration within its diverse scope. With a respectable 2023 impact factor placing it in the Q3 category across multiple relevant fields, including Neurology and Clinical Psychiatry, Advances in Autism serves as an essential resource for researchers, practitioners, and students alike, aiming to advance the understanding of autism and its related challenges. Although currently not open access, the journal provides various subscription options to facilitate widespread access to its cutting-edge insights and empirical studies, making it an indispensable tool for anyone invested in autism research.

Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

CHILD PSYCHIATRY & HUMAN DEVELOPMENT, published by Springer, stands at the forefront of research in the fields of developmental and educational psychology, pediatrics, perinatology, and child psychiatry. With an ISSN of 0009-398X and an E-ISSN of 1573-3327, this esteemed journal has been a vital resource for academics since its inception in 1970. Currently ranked in the Q1 category across its multiple relevant disciplines, it illustrates a significant impact with its Scopus rankings, placing it within the top 13% for pediatrics and child health and the top 18% for developmental psychology. Its comprehensive scope ensures that leading-edge studies, reviews, and discourse are accessible, contributing greatly to the understanding of mental health and developmental processes in children. With no open access option, the journal maintains a commitment to high-quality, peer-reviewed content that is invaluable for researchers, healthcare professionals, and students alike, as they strive to advance their knowledge and practices in child psychology and human development.

Pediatric Neurology, a prestigious journal published by Elsevier Science Inc, is a leading resource in the field of child neurology and developmental neurosciences. With an impressive impact factor and categorization in the Q1 and Q2 quartiles across several relevant fields, including Pediatrics, Neurology, and Developmental Neuroscience, this journal is essential for researchers and healthcare professionals focused on pediatric neurological disorders. Since its inception in 1985, it has provided a platform for high-quality research, clinical studies, and reviews that drive advancements in diagnosis, treatment, and understanding of neurological conditions in children. Although the journal does not currently offer open access, it maintains a robust reputation in the academic community, bolstered by its prominent ranking in Scopus metrics. By engaging with the latest findings published in Pediatric Neurology, readers will gain vital insights that contribute to improving pediatric healthcare outcomes in neurology and neuroscience.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Advances in Neurodevelopmental Disorders is a leading peer-reviewed journal published by SpringerNature, focusing on the critical intersection of psychology and social sciences as they pertain to neurodevelopmental disorders. With its ISSN 2366-7532 and E-ISSN 2366-7540, this journal has carved out a significant niche since its inception in 2017, particularly recognized for its influence in academia, evident from its category quartiles in 2023, which rank it Q3 in Psychology and Q2 in Social Sciences. The journal is committed to disseminating innovative research and knowledge that advance our understanding of neurodevelopmental disorders, making it an essential resource for researchers, professionals, and students dedicated to this field. With increasing citations and a respectable Scopus ranking—#209 in Social Sciences and #46 in Psychology—the journal continues to foster interdisciplinary dialogue and scientific advancement. Based in the Netherlands and published out of London, it offers a platform for open access to significant findings and discussions related to neurodevelopmental challenges, addressing a vital area of health that impacts individuals and families worldwide.